Study of Pregnancy Hormone Concentrations in Urban and Nomadic Mongolian Women
NCT01160549 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 412
Last updated 2020-03-16
Summary
International variation in breast cancer rates and data from migrant and animal studies support the possibility that exposures early in development, including the in utero period, play a role in breast carcinogenesis. One of the most striking prenatal influences on breast cancer risk is whether the woman was born in a country with a low or high breast cancer incidence. This observation has led to interest in the degree to which in utero exposures vary by the maternal environment, and to the hypothesis that alterations in prenatal concentrations of steroid hormones, particularly estrogens, and other biologic parameters to which the fetus is exposed mediate differences in subsequent breast cancer risk.
There are striking differences in breast cancer incidence rates between Asian and North American and Western European populations, but variation within Asia is also wide. Incidence in Mongolia is one of the lowest in the world (6.6/100,000) while China, its neighbor to the south, has about three times this rate (18.7/100,000). Furthermore, rates appear higher in urban than in rural areas. Over the last decade and a half Mongolia has experienced profound economic changes resulting in mass migration from a nomadic or semi-nomadic existence to a more western lifestyle in the capital city of Ulaanbaatar. Together with the contrast in exposures between traditional and urban settings, migration presents the opportunity to study women as they acculturate to a more western lifestyle.
We propose collecting maternal and cord blood samples from pregnant Mongolian women and their offspring living in rural and urban areas to describe concentrations of several steroid hormones and growth factors. The purpose of the study is to assess whether the in utero environment differs in women living a traditional lifestyle compared with a more urban lifestyle, and by degree of western acculturation among those who have recently migrated to the capital. Maternal and cord blood samples from an ongoing cohort study being conducted at the University of Pittsburgh will provide a comparison group of US women.
Conditions
- Pregnancy
Sponsors & Collaborators
-
National Cancer Institute (NCI)
lead NIH
Principal Investigators
-
Rebecca Troisi, D.Sc. · National Cancer Institute (NCI)
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-08-01
- Primary Completion
- 2013-07-15
- Completion
- 2015-02-19
Countries
- Mongolia
Study Locations
More Related Trials
-
Ultrasound-based Breast Cancer Screening in Chinese Women
NCT02268643 ·Status: UNKNOWN
-
Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Study
NCT00006425 ·Status: COMPLETED
-
Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer
NCT00329017 ·Status: WITHDRAWN
-
Comprehensive Genetic Assessment, Risk and Education in a Mammography Pilot
NCT04002986 ·Status: COMPLETED ·Phase: NA
-
Pregnant Women With a Breast Cancer Diagnosed Between 2000 and 2014
NCT01503034 ·Status: COMPLETED
-
Engaging Diverse Underserved Communities to Bridge the Mammography Divide
NCT01267110 ·Status: COMPLETED ·Phase: NA
-
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
NCT00823654 ·Status: RECRUITING
-
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
NCT00040222 ·Status: COMPLETED
-
Assessment of the Mutation of Pig-A Gene as Biomarker of Genotoxic Exposure in Humans
NCT02727868 ·Status: COMPLETED ·Phase: NA
-
Testing Digital Breast Tomosynthesis vs. Regular Mammogram in Detecting Breast Cancer in Women Having Screening Mammogram
NCT00535678 ·Status: COMPLETED
-
Safety of Pregnancy in BRCA Mutated Breast Cancer Patients
NCT03673306 ·Status: COMPLETED
-
Study of Genes and Environment in Patients With Breast Cancer in the East Anglia Region of the United Kingdom
NCT00757211 ·Status: UNKNOWN
-
Registry Study of Pregnancy and Breast Cancer
NCT04603820 ·Status: ACTIVE_NOT_RECRUITING
-
A Comparative Study of Mammography and Ultrasound for Breast Cancer Screening and Early Diagnosis
NCT04429269 ·Status: UNKNOWN
-
Towards Early Detection of Breast Cancer in High Risk Population
NCT05268913 ·Status: UNKNOWN
-
Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up Study
NCT00006421 ·Status: COMPLETED
-
Effect of Lifestyle Factors and Hormone Function on Breast Density in Healthy Hispanic Women Who Are Undergoing Mammography for Breast Cancer Screening
NCT00131950 ·Status: COMPLETED ·Phase: NA
-
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.
NCT05649072 ·Status: RECRUITING ·Phase: NA
-
Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer
NCT00001496 ·Status: COMPLETED
-
Clinical Value of Next Generation Sequencing in Endocrine Therapy for Advanced Hormone Receptor Positive/HER-2 Negative Breast Cancer
NCT03786575 ·Status: UNKNOWN ·Phase: NA
-
Universal Genetic Testing Versus Guidelines-Directed Testing for Germline Pathogenic Variants Among Non-Western Patients With Breast Cancer
NCT04920656 ·Status: COMPLETED
-
Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations
NCT00700778 ·Status: TERMINATED ·Phase: NA
-
Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Rlisk
NCT00839696 ·Status: COMPLETED
-
Understanding Decision Making Processes for Undergoing Genetic Testing Among Women With Newly Diagnosed Breast Cancer
NCT01386411 ·Status: COMPLETED
-
Changes in Breast Density and Breast Cancer Risk in Women With Breast Cancer and in Healthy Women
NCT00445445 ·Status: COMPLETED